Predictive value of immunologic parameters and HIV RNA in relation to humoral pneumococcal polysaccharide vaccine responses in patients with HIV infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 21, Issue 9, 2002, Pages 688-690

  Kvale, D ^a   Aaberge, I ^b,c   Froland S ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; DIPHTHERIA VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; VIRUS RNA;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE COUNT; PREDICTION; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME; VACCINATION;

EID: 0036392316     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-002-0803-4     Document Type: Article

References (12)

1. Janoff EN, Breiman RF, Daley CL, Hopewell PC (1992) Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 117:314-324
2. Centers For Disease Control (1997) 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 46(RR12):1-46
3. French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, Whitworth J, Gilks CF (2000) 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 355:2106-2111
4. Pinching AJ (1991) Antibody responses in HIV infection. Clin Exp Immunol 84:181-184
5. Kroon F, van Dissel JT, de Jong JC, van Furth R (1994) Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 8:469-476
6. Vandenbruaene M, Colebunders R, Mascart-Lemone F, Haerden Y, van Hove D, Peeters DM, Goeman J, van Royen P, Avonts D (1995) Equal IgG antibody response to pneumococcal vaccination in all stages of human immunodeficiency virus disease. J Infect Dis 172:551-553
7. Mond JJ, Lees A, Snapper CM (1995) T cell-independent antigens type 2. Ann Rev Immunol 13:655-692
8. Aaberge IS, Steinsvik TE, Groeng E-C, Leikvold R-B, Løvik M (1996) Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors. Clin Exp Immunol 105:12-17
9. Ancella-Parkk R (1993) Expanded European AIDS case definition. Lancet 341:441
10. Kvale D, Aukrust P, Osnes K, Bjerkeli V, Müller F, Frøland SS (1999) CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline and particularly rapid decrease of CD8+ lymphocytes predict AIDS. AIDS 13:195-201
11. Simonsen O, Bentzon MW, Heron I (1987) ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand 15:143-157
12. Cohen O, Cicala C, Vaccarezza M, Fauci AS (2000) The immunology of human immunodeficiency virus infection. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York, pp 1374-1397